Vivos Therapeutics, Inc. (VVOS) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Vivos Therapeutics, Inc. (VVOS) closed at USD 0.13 on 2026-10-14, a change of -94.8 % over the past year, with a market capitalization of USD 4.8M.

Vivos Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Vivos Therapeutics, Inc. key figures

Previous close

USD 0.13 (2026-10-14)

1-year change

-94.8 %

Market cap

USD 4.8M

Enterprise value

USD 14.54M

P/E ratio (trailing)

-0.08

P/E ratio (forward)

-0.17

EPS (trailing)

-1.88

EPS (forward)

-0.82

PEG ratio

n/a

Price to book

-0.42

Revenue growth

34.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.09

Employees

268

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Vivos Therapeutics, Inc. and compare it with other stocks.